Get ready for the next wave of pharmaceutical and medical device litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
Download a publication order form here or subscribe here.
Drugs & Medical Devices - Issue: 13
Judge Rules Plaintiffs Can Recover Attorney's Fees Under State Redhibition Laws, Denies Motion to Remand
Merck Claims Plaintiff's Motion for Class Certification Fails to Meet the Requirements of Rule 23
Woman Has No Evidence to Support LPLA Claims, Manufacturer Says in Motion for Summary Judgment
A Timeline of Verdicts and Decisions That Marked
the Drug & Supplement Litigation in 2002
Celebrex No More Effective Than Older Drugs
at Reducing the Risk of Recurrent Ulcer Bleeding
CMO Bank - January 2003
How Homeland Security Could Chock the Wheels of the Thimerosal Litigation
How Homeland Security Could Chock the Wheels of the Thimerosal Litigation
